No Data
Xiangyu Healthcare: Xiangyu Medical 2024 Annual Results Forecast
Xiangyu Medical 2024 Annual Results Forecast
Xiangyu Medical (688626.SH): The net income is expected to decrease by 51.57% to 58.18% in 2024.
On January 22, Glonghui reported that Xiangyu Medical (688626.SH) announced its performance forecast for 2024, expecting the net income attributable to owners of the parent company to be between 95 million yuan and 110 million yuan, a year-on-year decrease of 51.57% to 58.18%. It is expected that the net income attributable to owners of the parent company, excluding non-recurring gains and losses, will be between 82 million yuan and 95 million yuan, a year-on-year decrease of 53.44% to 59.81%. During the reporting period, facing opportunities and challenges, the company insists on technological innovation.
Xiangyu Medical (688626.SH): has repurchased a total of 3.0000% of the company's shares.
On December 27th, Gelonghui reported that Xiangyu Medical (688626.SH) announced that, in light of the previous two share repurchase plans, as of December 27, 2024, the company's dedicated repurchase securities Account has cumulatively repurchased 4,800,000 shares through centralized bidding transactions, accounting for 3.0000% of the company's total share capital of 160,000,000 shares, of which 4,380,000 shares were repurchased during the implementation period of the company's first two repurchase plans.
Xiangyu Medical Appoints Chair
Xiangyu Medical (688626.SH): Key technical staff member Ma Denwei has left.
Xiangyu Medical (688626.SH) announced that the company's core technician, Ma Denwei, has resigned from the company for personal reasons...
Investors Aren't Buying Xiangyu Medical Co.,Ltd's (SHSE:688626) Earnings
